Laura Sutcliffe

Stock Analyst at UBS

(1.56)
# 1564
Out of 5,368 analysts
8
Total ratings
80.00%
Success rate
12.43%
Average return
6 Stocks
Name Action PT Current % Upside Ratings Updated
RMD ResMed
Maintains: Buy
290 285
249.34 14.3% 1 Apr 24, 2025
TLX Telix Pharmaceutical...
Maintains: Strong Buy
21 22
16.09 36.73% 2 Jan 27, 2025
UCBJY UCB
Upgrades: Buy
n/a
n/a n/a 1 Aug 23, 2021
ARGX argenx
Initiates Coverage On: Buy
390
576.87 -32.39% 1 Jun 18, 2021
GNHAF Vifor Pharma AG
Upgrades: Neutral
n/a
n/a n/a 1 Mar 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 20, 2019